Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

97.51 +0.87 (+0.90%)
Official Closing Price Updated: 8:00 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,972,853
Open 97.61
Bid (Size) 97.49 (11)
Ask (Size) 97.70 (10)
Prev. Close 96.64
Today's Range 96.67 - 98.03
52wk Range 63.80 - 103.52
Shares Outstanding 736,000
Dividend Yield 0.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
BCYC: A Promising Play In The Biotech Sector
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a... 
Via Talk Markets
Topics ETFs

Performance

YTD
+8.07%
+8.07%
1 Month
-1.03%
-1.03%
3 Month
+6.32%
+6.32%
6 Month
+8.13%
+8.13%
1 Year
+35.15%
+35.15%

More News

Read More
A Biotech Breakout Will Be Led By Small Caps
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners
Via Talk Markets
Bearish Shooting Star Shines
Via Talk Markets
Topics ETFs
The Door Is Open, Time For The Fed To Act
Via Talk Markets
Topics Economy
Exposures Interest Rates
Stocks Hit Pause As Economic Uncertainty Tempers The Rally
Via Talk Markets
Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally
Via Talk Markets
Healthcare Stocks Are Coming On Strong In July Led By Biotech
Via Talk Markets
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Dow, The Russell, And The Biotech Sector Are Storming Higher
Via Talk Markets
Topics Stocks
Exposures US Equities
AskSlim Market Week - Friday, July 12
Via Talk Markets
Stocks Are Breaking Down Beneath The Surface
Via Talk Markets
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Via Benzinga
Topics ETFs
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Via Benzinga
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Via Benzinga
Topics Economy
Exposures Interest Rates
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
Via Talk Markets
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
Via InvestorPlace
American Express, Trade Desk And More: CNBC's 'Final Trades'
Via Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Via InvestorPlace
Should I Be Worried? Stock Market (And Sentiment Results)…
Via Talk Markets
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Via InvestorPlace
Exposures Product Safety
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.